Cheng Huang

发表

Clinical Study of Rituximab Combined with Chemotherapy in the Treatment of Lymphoma with Hypergammaglobulinemia

Ruiqing Liu, X. Wu, Guimin Zhao, 2021, Indian Journal of Pharmaceutical Sciences.

DCZ0014, a novel compound in the therapy of diffuse large B-cell lymphoma via the B cell receptor signaling pathway.

Weiliang Zhu, Zhijian Xu, Dandan Yu, 2020, Neoplasia.

A novel phosphoramide compound, DCZ0805, shows potent anti-myeloma activity via the NF-κB pathway

Weiliang Zhu, Zhijian Xu, Dandan Yu, 2021, Cancer cell international.

Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma

Weiliang Zhu, Gege Chen, Zhijian Xu, 2022, Journal of biomedical science.

HOXC10 promotes cell migration, invasion, and tumor growth in gastric carcinoma cells through upregulating proinflammatory cytokines

Ying Zhang, Boran Cheng, Xuan Wu, 2020, Journal of cellular physiology.

Treatment-induced cell cycle kinetics dictate tumor response to chemotherapy

G. Pond, J. Hassell, J. Draper, 2015, Oncotarget.

7-Ketocholesterol induces P-glycoprotein through PI3K/mTOR signaling in hepatoma cells.

Fu-Jen Kao, Nirmal Mazumder, F Peter Guengerich, 2013, Biochemical pharmacology.

DCZ0801, a novel compound, induces cell apoptosis and cell cycle arrest via MAPK pathway in multiple myeloma.

Weiliang Zhu, Zhijian Xu, Lu Gao, 2019, Acta biochimica et biophysica Sinica.

HMGB1 Translocation is Associated with Tumor-Associated Myeloid Cells and Involved in the Progression of Fibroblastic Sarcoma

Xiaoying Lin, Huoying Chen, Hongbo Liu, 2021, Pathology & Oncology Research.

Glycolysis is suppressed by DCZ0801-induced inactivation of the Akt/mTOR pathway in Multiple Myeloma

Weiliang Zhu, Zhijian Xu, Jumei Shi, 2020, Journal of Cancer.

Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation

Gege Chen, Zhijian Xu, Xiaosong Wu, 2023, Acta biochimica et biophysica Sinica.